Published in Diabetes on May 01, 2001
The role of gut hormones in glucose homeostasis. J Clin Invest (2007) 3.36
Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg (2004) 3.23
The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev (2008) 2.73
GIP and GLP-1, the two incretin hormones: Similarities and differences. J Diabetes Investig (2010) 2.40
Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet (2009) 2.29
Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? Diabetes (2010) 1.39
Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets. Am J Physiol Endocrinol Metab (2007) 1.22
Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg (2009) 1.20
Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat. Am J Physiol Gastrointest Liver Physiol (2010) 1.07
A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control. PLoS One (2010) 1.02
Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice. PLoS One (2013) 1.01
Alogliptin: a new addition to the class of DPP-4 inhibitors. Diabetes Metab Syndr Obes (2009) 0.98
Retracted Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment. J Diabetes Metab Disord (2015) 0.97
Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery. ISRN Endocrinol (2012) 0.94
Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice. PLoS One (2012) 0.90
Establishment of new clonal pancreatic β-cell lines (MIN6-K) useful for study of incretin/cyclic adenosine monophosphate signaling. J Diabetes Investig (2010) 0.87
Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide. World J Diabetes (2015) 0.86
Mechanism-based population modelling of the effects of vildagliptin on GLP-1, glucose and insulin in patients with type 2 diabetes. Br J Clin Pharmacol (2012) 0.86
β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes (2014) 0.86
Incretin hormones as immunomodulators of atherosclerosis. Front Endocrinol (Lausanne) (2012) 0.86
Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation. J Lipid Res (2011) 0.84
The Incretins and Pancreatic beta-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus. Korean Diabetes J (2010) 0.81
Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain. J Biol Chem (2011) 0.81
Metabolic surgery-principles and current concepts. Langenbecks Arch Surg (2011) 0.80
The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes. Prz Gastroenterol (2014) 0.78
Glucose-dependent insulinotropic polypeptide signaling in pancreatic β-cells and adipocytes. J Diabetes Investig (2012) 0.78
A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents. Diabetes Obes Metab (2013) 0.77
Glucose-Dependent Insulinotropic Peptide Level Is Associated with the Development of Type 2 Diabetes Mellitus. Endocrinol Metab (Seoul) (2016) 0.76
Effect of the combination of metformin and fenofibrate on glucose homeostasis in diabetic Goto-Kakizaki rats. Exp Mol Med (2013) 0.76
Dysfunction of intraflagellar transport-A causes hyperphagia-induced obesity and metabolic syndrome. Dis Model Mech (2016) 0.75
Npas4 Transcription Factor Expression Is Regulated by Calcium Signaling Pathways and Prevents Tacrolimus-induced Cytotoxicity in Pancreatic Beta Cells. J Biol Chem (2015) 0.75
Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15. J Diabetes Res (2015) 0.75
In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy. Nanoscale (2016) 0.75
AMPK is involved in the regulation of incretin receptors expression in pancreatic islets under a low glucose concentration. PLoS One (2013) 0.75
A dipeptidyl peptidase-4 inhibitor for adults with type 2 diabetes. P T (2010) 0.75
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology (1995) 3.17
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes (2000) 2.50
Inhibition of histamine-, pentagastrin-, and insulin-stimulated canine gastric secretion by pure "gastric inhibitory polypeptide". Gastroenterology (1972) 2.05
Glucose-dependent insulin release from genetically engineered K cells. Science (2000) 1.52
Cortical vein thrombosis misinterpreted as intracranial haemorrhage in severe ovarian hyperstimulation syndrome: case report. Hum Reprod (2000) 1.39
Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci U S A (1999) 1.37
Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab (1999) 1.37
Functional GIP receptors are present on adipocytes. Endocrinology (1998) 1.37
Preparation of highly active enterogastrone. Can J Physiol Pharmacol (1969) 1.30
Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice. Diabetes (1998) 1.28
Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women. Int J Epidemiol (2000) 1.25
Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice. Diabetologia (2008) 1.25
Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog. Diabetes (1975) 1.25
Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas. Diabetologia (2011) 1.23
A randomized trial of the use of print material and personal contact to improve mammography uptake among screening non-attenders in Singapore. Ann Acad Med Singapore (1998) 1.22
Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice. Diabetologia (2011) 1.17
Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes (1997) 1.16
Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes (1998) 1.10
Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol (1970) 1.10
Multiple forms of acetylcholinesterase from pig brain. Biochem J (1973) 1.09
The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas. Endocrinology (1976) 1.08
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice. Endocrinology (2000) 1.08
Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP). FEBS Lett (1981) 1.06
Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. J Clin Endocrinol Metab (2001) 1.05
Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. J Clin Invest (1996) 1.05
Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation. Hum Reprod (2001) 1.03
Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs. J Biol Chem (2000) 1.01
Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor complementary DNA. Mol Endocrinol (2000) 1.00
Gastrin secretion from human antral G cells in culture. Gastroenterology (1990) 1.00
Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling. Biochem Biophys Res Commun (1996) 0.97
Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann Acad Med Singapore (1998) 0.97
Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide. Metabolism (1999) 0.97
Gastric inhibitory polypeptide release from a tumor-derived cell line. Am J Physiol (1995) 0.97
Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin. Endocrinology (1999) 0.96
New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser. Diabetologia (2010) 0.95
Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. Endocrinology (1995) 0.94
Central somatostatin systems revealed with monoclonal antibodies. J Comp Neurol (1985) 0.94
The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation. Diabetologia (2012) 0.93
Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide. Diabetologia (2012) 0.93
An immunocytochemical investigation with monoclonal antibodies to somatostatin. Histochemistry (1985) 0.92
Factors determining acceptability of mammography in an Asian population: a study among women in Singapore. Cancer Causes Control (1997) 0.92
Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas. Endocrinology (1978) 0.92
Musashi expression in β-cells coordinates insulin expression, apoptosis and proliferation in response to endoplasmic reticulum stress in diabetes. Cell Death Dis (2011) 0.92
Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist. Endocrinology (2000) 0.91
Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3. Diabetologia (2010) 0.91
Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP). Biochim Biophys Acta (2001) 0.91
Pathophysiology of itching. Lancet (1996) 0.91
Novel germline BRCA1 mutations detected in women in singapore who developed breast carcinoma before the age of 36 years. Cancer (2000) 0.91
Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA. Clin Cancer Res (1999) 0.90
Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabet Med (2000) 0.90
Pathologic-radiologic correlations in screen-detected ductal carcinoma in situ of the breast: findings of the Singapore breast screening project. Int J Cancer (2000) 0.90
Morphological and functional alterations to a sub-group of regulatory peptides in human pancreas and intestine after jejuno-ileal bypass. Int J Obes Relat Metab Disord (1993) 0.89
The insulinotropic action of gastric inhibitory polypeptide. Can J Physiol Pharmacol (1975) 0.89
Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY. Diabetologia (2006) 0.89
Effect of aging and diabetes on the enteroinsular axis. J Gerontol A Biol Sci Med Sci (2001) 0.89
Gastric inhibitory polypeptide stimulated secretion of somatostatinlike immunoreactivity from the stomach: inhibition by acetylcholine or vagal stimulation. Can J Physiol Pharmacol (1981) 0.88
Reprogramming gut and pancreas endocrine cells to treat diabetes. Diabetes Obes Metab (2011) 0.88
Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231. Clin Cancer Res (2001) 0.88
Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor. Endocrinology (1997) 0.88
DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes. Gene Ther (2009) 0.88
A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion. J Biol Chem (2001) 0.88
Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice. Diabetologia (2011) 0.87
Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes Care (2001) 0.87
Serum IGF-binding protein-6 and prostate specific antigen in breast cancer. Eur J Endocrinol (1999) 0.87
Atherogenesis in two strains of obese rats. The fatty Zucker and LA/N-corpulent. Atherosclerosis (1988) 0.86
A multiparameter study on the action of preparations containing cholecystokinin-pancreozymin. Scand J Gastroenterol (1970) 0.86
The subcellular localization of acetylcholinesterase and its molecular forms in pig cerebral cortex. J Neurochem (1976) 0.86
Leptin reduces glucose transport and cellular ATP levels in INS-1 beta-cells. J Mol Endocrinol (2004) 0.86
Distal middle cerebral artery aneurysms. Endovascular treatment results with literature review. Interv Neuroradiol (2004) 0.86
Metabolism of glucagon by dipeptidyl peptidase IV (CD26). Regul Pept (2001) 0.85
Leptin resistance following over-expression of protein tyrosine phosphatase 1B in liver. J Mol Endocrinol (2006) 0.85
Deletions within the azoospermia factor subregions of the Y chromosome in Hong Kong Chinese men with severe male-factor infertility: controlled clinical study. Hong Kong Med J (2000) 0.84
Five micro-curie urea breath test for the diagnosis of Helicobacter pylori infection: evaluation in a South-East Asian population. Aust N Z J Surg (1999) 0.84
Ultrasound-guided embryo transfer: a prospective randomized controlled trial. Hum Reprod (2001) 0.84
Effect of exercise on augmented aortic vasoconstriction in the db/db mouse model of type-II diabetes. Physiol Res (2007) 0.84
Autoradiographic localization of binding sites for atrial natriuretic factor. Can J Physiol Pharmacol (1985) 0.84
Characterization of the carboxyl-terminal domain of the rat glucose-dependent insulinotropic polypeptide (GIP) receptor. A role for serines 426 and 427 in regulating the rate of internalization. J Biol Chem (1999) 0.84
Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats. Diabetologia (1993) 0.83
The enteroinsular axis in dipeptidyl peptidase IV-negative rats. Metabolism (1996) 0.83